secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2024-11-06T23:59:59+00:00
Accession:  0001493152-24-043862
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Apparatus Regenerative Technology signs exclusive global distribution deal with Health Regen through 2030
--------------------------------------------------------------------------------

- Exclusive distribution of consumer health/dietary supplements from Nov 1, 2024 to Dec 31, 2030; auto-renews for 6 years if targets met.
- Annual sales targets: $1M (2025) escalating to $20M (2030); Company receives 10% markup on manufacturing costs plus pass-through costs.
- Early termination by Company triggers penalty of 3x projected annual sales in year 6.
- Chinese subsidiary employees and inventory to be transferred to Health Regen effective Nov 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000149315224043862/0001493152-24-043862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000149315224043862/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer